Suggested Remit: To appraise the clinical and cost effectiveness of nintedanib with pemetrexed and cisplatin followed by nintedanib monotherapy within its marketing authorisation for untreated unresectable malignant pleural mesothelioma.
The company have informed us that they are no longer seeking regulatory approval in this indication. Therefore the appraisal is suspended.
 
Status Discontinued
Technology type Medicine
Decision Selected
Process TA
ID number 1424

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
25 August 2022 Discontinued. The company have informed us that they are no longer seeking regulatory approval in this indication. Therefore the appraisal is suspended.
20 July 2020 The Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of nintedanib for untreated malignant pleural mesothelioma. For information, the company have advised that they are no longer pursuing a Marketing Authorisation Application from the European Medicines Agency for this indication at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme. As this appraisal has been referred NICE will continue to monitor any development and will update interested parties if the situation changes.
09 March 2020 The Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal (STA) of nintedanib for untreated malignant pleural mesothelioma. Following a recent update from the company, NICE has decided to suspend this appraisal on its work programme. As the appraisal has been referred, NICE will continue to monitor any developments and will provide a further update in due course.
09 March 2020 Suspended. Topic is suspended
11 June 2018 - 09 July 2018 Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators
24 April 2018 In progress. DHSC Referral Received

For further information on our processes and methods, please see our CHTE processes and methods manual